World Health Organization Raises Concern Over Severe Scarcity of Obesity Medications
Less than 10% of patients who could benefit from weight-loss injections such as Wegovy have access to them, states the global health agency as it issues its initial advice on the drugs.
Given in excess of 1,000,000,000 individuals worldwide now living with obesity, it is calling for broader and more equitable access to these injectable treatments.
According to projections, over two billion are projected to be living with obesity by 2030 without intervention.
"Our latest guidance affirms that obesity is a chronic disease that can be addressed with thorough and lifelong care," remarked the agency's head Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and supply-chain constraints are key hurdles to universal access to the jabs that can help people shift significant body mass, explains the agency.
GLP-1 Therapy Supply Crisis
Despite the current most optimistic case, the production of such drugs would only suffice for about 100 million people – under 10% of those who need them, per the health organization.
The guideline encourages nations and manufacturers to widen access, through measures like voluntary licensing.
The intellectual property rights on a key compound – the main ingredient of the drug Wegovy – is scheduled to end in a number of countries in 2026.
How Obesity Drugs Operate
These medications replicate a natural hormone to reduce digestion speed, reduce hunger and increase the sense of being full so people eat less.
Individuals usually start to lose weight within a few weeks of starting on the once-weekly jabs.
Research indicates people may regain a significant portion after a year of halting the treatment, as their normal food cravings come back.
Being above a healthy weight elevates your risk for experiencing health problems, like type 2 diabetes, heart disease, brain attack, and specific cancers.
Obesity affects individuals in every country and was linked to over three and a half million fatalities worldwide in 2024, as per the health agency.
